Knocking down barriers: advances in siRNA delivery (vol 8, pg 129, 2009)

被引：17
|
作者：
Whitehead, Kathryn A.
Langer, Robert
Anderson, Daniel G.
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 06期
关键词：
D O I：
10.1038/nrd2919-c1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Nature Reviews Drug Discovery 8, 129–138 (2009) | 10.1038/nrd2742 On page 136 in Table 3, the clinical trial for acute renal failure has been attributed to Quark/Pfizer when it should be attributed to Quark alone. In addition, the authors would like to clarify that, following a Phase I/II trial in patients with wet age-related macular degeneration, the siRNA drug candidate PF-4523655 (RTP801i-14) is now being studied in a Phase II trial for diabetic macular oedema conducted by Pfizer in collaboration with Quark.
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] Knocking down barriers: advances in siRNA delivery (vol 8, pg 129, 2009)
    Whitehead, Kathryn A.
    Langer, Robert
    Anderson, Daniel G.
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (05) : 412 - 412
  • [2] Knocking Down Barriers: Advances in siRNA Delivery
    Rajeev, Anjaly
    Siby, Aiswarya
    Koottungal, Merin James
    George, Jinu
    John, Franklin
    CHEMISTRYSELECT, 2021, 6 (46): : 13350 - 13362
  • [3] Knocking down barriers: advances in siRNA delivery
    Kathryn A. Whitehead
    Robert Langer
    Daniel G. Anderson
    Nature Reviews Drug Discovery, 2009, 8 : 129 - 138
  • [4] Knocking down barriers: advances in siRNA delivery
    Whitehead, Kathryn A.
    Langer, Robert
    Anderson, Daniel G.
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 129 - 138
  • [5] Erratum: Knocking down barriers: advances in siRNA delivery
    Kathryn A. Whitehead
    Robert Langer
    Daniel G. Anderson
    Nature Reviews Drug Discovery, 2009, 8 : 516 - 516
  • [6] Erratum: Knocking down barriers: advances in siRNA delivery
    Kathryn A. Whitehead
    Robert Langer
    Daniel G. Anderson
    Nature Reviews Drug Discovery, 2010, 9 : 412 - 412
  • [7] Enhanced antitumor efficacies of multifunctional nanocomplexes through knocking down the barriers for siRNA delivery
    Han, Lu
    Tang, Cui
    Yin, Chunhua
    BIOMATERIALS, 2015, 44 : 111 - 121
  • [8] Polymersome delivery of siRNA and antisense oligonucleotides (vol 134, pg 132, 2009)
    Kim, Younghoon
    Tewari, Manorama
    Pajerowski, J. David
    Cai, Shenshen
    Sen, Shamik
    Williams, Jason H.
    Sirsi, Shashank R.
    Lutz, Gordon J.
    Discher, Dennis E.
    JOURNAL OF CONTROLLED RELEASE, 2009, 137 (3-4) : 256 - 256
  • [9] Breaking down the barriers: siRNA delivery and endosome escape
    Dominska, Monika
    Dykxhoorn, Derek M.
    JOURNAL OF CELL SCIENCE, 2010, 123 (08) : 1183 - 1189
  • [10] Polymeric siRNA delivery vectors: knocking down cancers with polymeric-based gene delivery systems
    Ardana, Aditya
    Whittaker, Andrew K.
    McMillan, Nigel A. J.
    Thurecht, Kristofer J.
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2015, 90 (07) : 1196 - 1208
12345